VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
BCG Tice
Preclinical
Small molecule
U
University of Oxford
1
Indications
2
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
BCG
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
BCG
Preclinical
Completed
Clinical
Trials by Indication
[1]
BCG
1 trial
A Clinical Challenge Study of BCG in Healthy Volunteers
Completed
·
U
University of Oxford
·
N/A
·
NCT02088892
·
52 enrolled
Adult
1 trial
Study of AERAS 422 in Healthy Adults
Completed
·
A
Aeras
·
Phase 1
·
NCT01340820
·
24 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
2 trial records for BCG Tice. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
BCG Tice compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for BCG Tice. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
University of Oxford company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
U
University of Oxford
Related News